[Hemodynamic changes due to diphenylhydantoin in digitalized heart patients].
D001145:Arrhythmias, Cardiac / Q000517:prevention & control; D001784:Blood Gas Analysis; D001794:Blood Pressure / Q000187:drug effects; D006328:Cardiac Catheterization; D002302:Cardiac Output / Q000187:drug effects; D002306:Cardiac Volume / Q000187:drug effects; D004071:Digitalis Glycosides / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006948:Hyperkinesis / Q000139:chemically induced; D000860:Hypoxia / Q000139:chemically induced; D007275:Injections, Intravenous; D009461:Neurologic Manifestations; D010100:Oxygen / Q000097:blood; D010672:Phenytoin / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D012131:Respiratory Insufficiency / Q000139:chemically induced; D012997:Solvents / Q000009:adverse effects; D014655:Vascular Resistance / Q000187:drug effects
D004071:Digitalis Glycosides; D012997:Solvents; D010672:Phenytoin; D010100:Oxygen
Hämodynamische Veränderungen durch Diphenylhydantoin bei digitalisierten Herzkranken.